Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Prokopczyk, B.
Right arrow Articles by El-Bayoumy, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prokopczyk, B.
Right arrow Articles by El-Bayoumy, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 22, No. 1, 107-114, January 2001
© 2001 Oxford University Press


CANCER BIOLOGY

Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via {alpha}-hydroxylation and carbonyl reduction pathways

Bogdan Prokopczyk2, Neil Trushin, Joanna Leszczynska, Steven E. Waggoner1 and Karam El-Bayoumy

American Health Foundation, Valhalla, NY 10595 and
1 Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA

We determined the ability of human epithelial cervical cells, human cervical microsomes and cytosol to metabolize 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). All preparations metabolized NNK by {alpha}-hydroxylation, demonstrated by the presence of 4-oxo-4-(3-pyridyl)butyric acid (keto acid), and by carbonyl reduction, illustrated by the formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL). Cervical cells metabolized NNK by the oxidative pathway to an extent comparable to that by the reductive pathway. In both human cervical cytosol and microsomes, the concentration of {alpha}-hydroxylation products ranged from undetectable to 10 times lower than those of NNAL. An apparent Km and Vmax of 7075 µM and 650 pmol/mg/min, respectively, were determined for the keto acid in one microsomal preparation. NNAL was formed in all preparations at the highest levels, ranging from 16.9 to 35.5 pmol/106 cells in incubations with ectocervical cells and 6.2 pmol/106 cells in incubations with endocervical cells. NNAL levels were 1.88–4.95 and 1.44–2.08 pmol/mg/min in human cervical microsomes and cytosolic fractions, respectively. An apparent Km of 739 µM and a Vmax of 1395 pmol/mg/min for NNAL formation were established in the same microsomal preparation used for the keto acid kinetics study. The stereochemistry of the NNAL formed in incubations of NNK with human cervical cells and subcellular fractions was determined by derivatization with (S)-(–)-methylbenzyl isocyanate. Human cervical cells and microsomes both formed the (R)-enantiomer of NNAL almost exclusively; incubations with human cervical cytosol resulted predominantly in the formation of the (S)-enantiomer. Substrates for 11ß-hydroxysteroid dehydrogenase, cortisone, glycyrrhizic acid and metyrapone all inhibited the formation of NNAL in incubations with human cervical microsomes; the inhibition ranged from 16% to 80%. These studies illustrate that human cervical tissue can metabolize NNK by both oxidative and reductive pathways and that 11ß-HSD may, in part, be responsible for the carbonyl reduction of NNK.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. J. Wiley, E. Wiesmeier, E. Masongsong, K. H. Gylys, L. A. Koutsky, D. G. Ferris, E. Barr, J. Yu Rao, and The Proof of Principle Study Investigative Group
Smokers at higher risk for undetected antibody for oncogenic human papillomavirus type 16 infection.
Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 915 - 920.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.